In vivo regulation of mRNA expression of vascular endothelial growth factor receptors (KDR and flt-1) in the human oviduct  Po Mui Lam, M.R.C.O.G., Christine.

Slides:



Advertisements
Similar presentations
Ovulation and Menstruation. Function of Menstrual Cycle Uterine walls thickens with rich blood supply in preparation for a fertilized egg If fertilization.
Advertisements

Menstruation IF fertilization does NOT take place
Diminished ovarian reserve as measured by means of baseline follicle-stimulating hormone and antral follicle count is not associated with pregnancy loss.
Variation in circulating antimüllerian hormone precursor during the periovulatory and acute postovulatory phases of the human ovarian cycle  Michael W.
Male contraception Fertility and Sterility
Leptin levels and luteinizing hormone pulsatility in normal cycling women and their relationship to daily changes in metabolic rate  Rebecca M. Fenichel,
The normal variabilities of the menstrual cycle
Concentrations of stromal cell-derived factor-1 and vascular endothelial growth factor in relation to the diameter of human follicles  Akemi Nishigaki,
Regulation of vascular endothelial growth factor-A and its soluble receptor sFlt-1 by luteinizing hormone in vivo: implication for ovarian follicle angiogenesis 
Impact of final oocyte maturation using gonadotropin-releasing hormone agonist triggering and different luteal support protocols on endometrial gene expression 
The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation.
Growth rates of ovarian follicles during natural menstrual cycles, oral contraception cycles, and ovarian stimulation cycles  Angela R. Baerwald, Ph.D.,
Guoying Dong, B. S. , Yueshuai Guo, B. S. , Huarong Cao, B. S
Progestins inhibit estradiol-induced vascular endothelial growth factor and stromal cell– derived factor 1 in human endometrial stromal cells  Hidetaka.
Increased messenger RNA expression of vascular endothelial growth factor and its receptors in the implantation site of the human oviduct with ectopic.
Hakan Cakmak, M. D. , Audra Katz, R. N. , Marcelle I. Cedars, M. D
Zeev Shoham, M.D.  Fertility and Sterility 
Induction of proteinases in the human preovulatory follicle of the menstrual cycle by human chorionic gonadotropin  Katherine L. Rosewell, B.A., Linah.
The measurements of RAGE, VEGF, and AGEs in the plasma and follicular fluid of reproductive women: the influence of aging  Eriko Y. Fujii, M.D., Ph.D.,
Diminished ovarian reserve as measured by means of baseline follicle-stimulating hormone and antral follicle count is not associated with pregnancy loss.
Sana M. Salih, M. D. , Salama A. Salama, Ph. D. , Amin A. Fadl, Ph. D
High serum luteinizing hormone and testosterone concentrations do not predict pregnancy outcome in women with recurrent miscarriage  Luciano G Nardo,
A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data 
Leptin levels and luteinizing hormone pulsatility in normal cycling women and their relationship to daily changes in metabolic rate  Rebecca M. Fenichel,
Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine.
Prevalence of premature urinary luteinizing hormone surges in women with regular menstrual cycles and its effect on implantation of frozen-thawed embryos 
Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response  Frank.
Microdose flare protocol with interrupted follicle stimulating hormone and added androgen for poor responders—an observational pilot study  Frederic Mitri,
Rahi Victory, M. D. , F. R. C. S. C. , Ghassan M. Saed, Ph. D
Vascular endothelial growth factor polymorphisms (−460C/T, +405G/C, and 936C/T) and endometriosis: their influence on vascular endothelial growth factor expression 
Serum luteinizing hormone levels are markedly increased and significantly correlated with Δ4-androstenedione levels in lean women with polycystic ovary.
Susanna J. Park, M. D. , Laura T. Goldsmith, Ph. D. , Joan H
Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization/intracytoplasmic.
Tomer Singer, M. D. , David H. Barad, M. D. , M. S
Fertility and Sterility
Modulation of HOXA10 and other markers of endometrial receptivity by age and human chorionic gonadotropin in an endometrial explant model  Robin H. Fogle,
Does Testosterone Have a Role in Erectile Function?
Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles: a meta-analysis  Rina Agrawal,
Anti-Müllerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells  Laura Pellatt, Ph.D., Suman Rice, Ph.D.,
Diminished intrafollicular estradiol levels in in vitro fertilization cycles from women with reduced ovarian response to recombinant human follicle-stimulating.
Human chorionic gonadotropin and 17-β estradiol regulation of human oviductin/oviduct specific glycoprotein mRNA expression in vitro  Christine Briton-Jones,
Clinical and endocrine response to the withdrawal of gonadotropin-releasing hormone agonists during prolonged coasting  Basil Ho Yuen, M.B., Ch.B., Tuan-Anh.
Concentrations of inhibins and activin in women undergoing stimulation with recombinant follicle-stimulating hormone for in vitro fertilization treatment 
Mean versus individual hormonal profiles in the menstrual cycle
CDB-2914, a novel selective progesterone receptor modulator, differentially regulates endometrial gene expression in the proliferative phase of the menstrual.
Endocrine gland–derived vascular endothelial growth factor concentrations in follicular fluid and serum may predict ovarian hyperstimulation syndrome.
Comparison of basal follicle-stimulating hormone versus the clomiphene citrate challenge test for ovarian reserve screening  Tarun Jain, M.D., Michael.
Concentration of vascular endothelial growth factor released by cultured human luteinized granulosa cells is higher in women with polycystic ovaries than.
Regulation of human oviductin mRNA expression in vivo
Serum resistin levels in women with polycystic ovary syndrome
Effects of growth hormone and insulin-like growth factor 1 on progesterone production in human luteinized granulosa cells  Toshiaki Taketani, M.D., Yoshiaki.
Decreased levels of interleukin-18 in peritoneal fluid but not in serum of patients with endometriosis  Xinmei Zhang, M.D., Jun Lin, M.D., Yuli Qian,
Human granulosa-lutein cell in vitro production of progesterone, inhibin A, inhibin B, and activin A are dependent on follicular size and not the presence.
Effects of levonorgestrel, medroxyprogesterone acetate, norethindrone, and 17β- estradiol on vascular endothelial growth factor isomers 121 and 165 in.
The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is.
Effectiveness of cetrorelix for the prevention of premature luteinizing hormone surge during controlled ovarian stimulation using letrozole and gonadotropins:
Upregulation of mRNA expression of vascular endothelial growth factor and its receptors by exogenous human chorionic gonadotropin in cultured oviduct.
Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing.
Use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection.
Chronology of hemodynamic changes in asymptomatic in vitro fertilization patients and relationship with ovarian steroids and cytokines  Dolors Manau,
The reproductive and metabolic effect of rosiglitazone on Chinese women with polycystic ovarian syndrome—a double-blind randomized placebo-controlled.
Urine vascular endothelial growth factor-A is not a useful marker for endometriosis  Clariss Potlog-Nahari, M.D., Pamela Stratton, M.D., Craig Winkel,
Bone morphogenetic protein 7 (BMP-7) increases the expression of follicle-stimulating hormone (FSH) receptor in human granulosa cells  Jia Shi, M.D.,
Direct injection of vascular endothelial growth factor into the ovary of mice promotes follicular development  Ramiro Quintana, M.D., Laura Kopcow, M.D.,
Serum levels of soluble vascular cell adhesion molecule-1 are decreased in women receiving oral contraceptives compared with normally menstruating women:
Serum pattern of circulating free leptin, bound leptin, and soluble leptin receptor in the physiological menstrual cycle  Franz Geisthövel, M.D., Nicoline.
Microdose gonadotropin-releasing hormone agonist in the absence of exogenous gonadotropins is not sufficient to induce multiple follicle development 
Defining the “sweet spot” for administered luteinizing hormone-to-follicle-stimulating hormone gonadotropin ratios during ovarian stimulation to protect.
Intrafollicular antimüllerian hormone levels predict follicle responsiveness to follicle- stimulating hormone (FSH) in normoandrogenic ovulatory women.
Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome  Ernesto Bosch,
Presentation transcript:

In vivo regulation of mRNA expression of vascular endothelial growth factor receptors (KDR and flt-1) in the human oviduct  Po Mui Lam, M.R.C.O.G., Christine Briton-Jones, B.Sc., Che Kwok Cheung, B.Sc., Ingrid Hung Lok, M.R.C.O.G., Lai Ping Cheung, M.R.C.O.G., Christopher Haines, M.D.  Fertility and Sterility  Volume 81, Issue 2, Pages 416-423 (February 2004) DOI: 10.1016/j.fertnstert.2003.06.025

Figure 1 The modulation of mean VEGF-R/β-actin ratio in various oviduct regions and in various stages of an ovulatory cycle. (A) For flt-1. (B) For KDR. (yellow bar = isthmus; blue bar = ampulla; red bar = infundibulum) Error bars show the standard error of the mean. The significant differences between the periovulatory stage and other stages in the corresponding oviduct regions are marked with #; P<.05. The significant differences between infundibulum or ampulla and isthmus in the corresponding menstrual stages are marked with *; P < .05. Lam. VEGF receptors in the human oviduct.Fertil Steril 2004. Fertility and Sterility 2004 81, 416-423DOI: (10.1016/j.fertnstert.2003.06.025)

Figure 2 Scatter plots illustrating the correlation between the normalized flt/β-actin ratio and serum hormonal concentrations. (A) For luteinizing hormone, LH. (B) For follicle stimulating hormone, FSH. (C) For estradiol, E2. (D) For progesterone, P. Lam. VEGF receptors in the human oviduct. Fertil Steril 2004. Fertility and Sterility 2004 81, 416-423DOI: (10.1016/j.fertnstert.2003.06.025)

Figure 3 Scatter plots illustrating the correlation between the normalized KDR/β-actin ratio and serum hormonal concentrations. (A) For luteinizing hormone, LH. (B) For follicle stimulating hormone, FSH. (C) For estradiol, E2. (D) For progesterone, P. Lam. VEGF receptors in the human oviduct. Fertil Steril 2004. Fertility and Sterility 2004 81, 416-423DOI: (10.1016/j.fertnstert.2003.06.025)